About Zenotech Laboratories Limited
Data last updated: 20 December 2025
Zenotech Laboratories Limited is a public limited company based in Hyd, Telangana, India, a subsidiary of Sun Pharmaceutical Industries Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 15 June 1989, the company has been in operation for over 37 years.
Registered with ROC Hyderabad under CIN L27100TG1989PLC010122. Listed on BSE: 532039.
Capital: an authorised share capital of ₹100 Cr and a paid-up capital of ₹61.03 Cr. It is led by directors including Rakeshchandra Jagdishprasad Sinha and Jignesh Anantray Goradia.
Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyd, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.6 Cr, a growth of 7% compared to the previous year.
The company has a workforce of approximately 181 employees as per the latest available data. It operates as a subsidiary of Sun Pharmaceutical Industries Limited.
The company is associated with 1 brand - Zenotech Laboratories. As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹64.71 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zenotechlab.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressSurvey No.250 – 252 Turkapally Village Genome Valley Road, Shamirpet Mandal Medchal – Malkajgiri District, Hyd, Telangana, India – 500101
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Zenotech Laboratories Limited
Zenotech Laboratories Limited has one previous CIN (Corporate Identification Number): L27100AP1989PLC010122. The current CIN is L27100TG1989PLC010122, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L27100TG1989PLC010122 | Current |
| L27100AP1989PLC010122 | Previous |
Associated Brands with Zenotech Laboratories Limited
Zenotech Laboratories Limited operates one associated brand: Zenotech Laboratories. These brands represent Zenotech Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic injectables for oncology and anesthesiology are manufactured. | zenotechlab.com |
Business Activity of Zenotech Laboratories Limited
Zenotech Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Zenotech Laboratories Limited
Zenotech Laboratories Limited is audited by G S K A & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| G S K A & Co. (ICAI peer reviewed, certificate valid till 2027-10-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Zenotech Laboratories Limited
Zenotech Laboratories Limited is currently managed by 10 directors, with 42 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rakeshchandra Jagdishprasad Sinha
Also directs:
Caraco Pharmaceuticals Private Limited, Sun Pharma Laboratories Limited, Neetnav Real Estate Private Limited and 4 more
|
Director | 01 Feb 2020 | 6 Years 5 Months | Current |
| Jignesh Anantray Goradia | Director | 08 Jul 2015 | 11 Years 0 Months | Current |
|
Premal Hemant Gandhi
Also directs:
Dheevit Consultant Private Limited, Keshava Foundation For Educare
|
Director | 28 Jan 2025 | 1 Years 5 Months | Current |
|
Chintan Jitendra Shah
Also directs:
Knk Trading Private Limited, Dosti Realty Limited
|
Director | 27 Jan 2016 | 10 Years 5 Months | Current |
|
Jagruti Prashant Sheth
Also directs:
Monika Alcobev Limited
|
Director | 01 Feb 2020 | 6 Years 5 Months | Current |
| Azadar Husain Asghar Mehdi Khan | Director | 25 Aug 2015 | 10 Years 10 Months | Current |
Financials of Zenotech Laboratories Limited FY 2026 filings available
Zenotech Laboratories Limited reported revenue of ₹39.56 Cr (up 1.5% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹39.56 Cr | ₹38.98 Cr | ₹36.76 Cr | ₹38.35 Cr | ₹36.57 Cr | ₹22.45 Cr | ₹25.94 Cr | ₹13.03 Cr |
| Other Income | ₹6.36 Cr | ₹5.62 Cr | ₹5.08 Cr | ₹5.16 Cr | ₹62.93 Lakh | ₹40.84 Lakh | ₹1.25 Cr | ₹4.71 Cr |
| Total Income | ₹45.92 Cr | ₹44.6 Cr | ₹41.84 Cr | ₹43.51 Cr | ₹37.19 Cr | ₹22.85 Cr | ₹27.19 Cr | ₹17.74 Cr |
| Cost of Materials Consumed | ₹0 | ₹84.02 Lakh | ₹0 | ₹6.08 Lakh | ₹11,000 | ₹3.22 Lakh | ₹50.45 Lakh | ₹70.55 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.19 Lakh |
| Employee Benefit Expense | ₹15.53 Cr | ₹12.38 Cr | ₹9.46 Cr | ₹7.88 Cr | ₹7.1 Cr | ₹6.49 Cr | ₹5.76 Cr | ₹4.98 Cr |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹11.22 Lakh | ₹1.22 Cr | ₹1.55 Cr | ₹89.25 Lakh | ₹11.77 Lakh |
| Depreciation & Amortisation | ₹7.11 Cr | ₹6.96 Cr | ₹7.09 Cr | ₹7.17 Cr | ₹6.97 Cr | ₹6.46 Cr | ₹4.85 Cr | ₹4.2 Cr |
| Other Expenses | ₹18.9 Cr | ₹15.65 Cr | ₹14.15 Cr | ₹13.78 Cr | ₹12.01 Cr | ₹9.54 Cr | ₹10.77 Cr | ₹10.85 Cr |
| Total Expenses | ₹41.54 Cr | ₹35.83 Cr | ₹30.7 Cr | ₹29.01 Cr | ₹27.29 Cr | ₹24.07 Cr | ₹22.78 Cr | ₹20.87 Cr |
| Profit Before Exceptional Items & Tax | ₹4.38 Cr | ₹8.77 Cr | ₹11.14 Cr | ₹14.5 Cr | ₹9.9 Cr | -₹1.22 Cr | ₹4.41 Cr | -₹3.13 Cr |
| Exceptional Items | -₹19.51 Lakh | ₹1.92 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹6.37 Cr | ₹0 |
| Profit Before Tax | ₹4.19 Cr | ₹10.69 Cr | ₹11.14 Cr | ₹14.5 Cr | ₹9.9 Cr | -₹1.22 Cr | ₹10.78 Cr | -₹3.13 Cr |
| Total Tax Expense | ₹5.26 Cr | ₹5.08 Cr | ₹2.83 Cr | ₹2.92 Cr | -₹12.27 Cr | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹1.07 Cr | ₹5.61 Cr | ₹8.31 Cr | ₹11.59 Cr | ₹22.18 Cr | -₹1.22 Cr | ₹10.78 Cr | -₹3.13 Cr |
| Other Comprehensive Income | ₹4.67 Lakh | -₹1.68 Lakh | -₹3.84 Lakh | ₹3.35 Lakh | ₹5.6 Lakh | -₹57,000 | -₹4.68 Lakh | ₹77,000 |
| Total Comprehensive Income | -₹1.03 Cr | ₹5.6 Cr | ₹8.27 Cr | ₹11.62 Cr | ₹22.23 Cr | -₹1.22 Cr | ₹10.73 Cr | -₹3.12 Cr |
| EBITDA (computed) | ₹11.5 Cr | ₹15.73 Cr | ₹18.23 Cr | ₹21.79 Cr | ₹18.09 Cr | ₹6.79 Cr | ₹10.15 Cr | ₹1.19 Cr |
| Basic EPS | ₹-0.18 | ₹0.92 | ₹1.36 | ₹1.90 | ₹3.63 | ₹-0.20 | ₹1.77 | ₹-0.51 |
| Diluted EPS | ₹-0.18 | ₹0.00 | ₹1.36 | ₹1.90 | ₹3.63 | ₹-0.20 | ₹1.77 | ₹-0.51 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹111.15 Cr | ₹111.03 Cr | ₹106.21 Cr | ₹100.87 Cr | ₹94.08 Cr | ₹85.84 Cr | ₹85.55 Cr | ₹84.58 Cr |
| Non-current Assets | ₹70.11 Cr | ₹75.04 Cr | ₹80.04 Cr | ₹84.61 Cr | ₹86.71 Cr | ₹78.5 Cr | ₹79.85 Cr | ₹65.39 Cr |
| Current Assets | ₹41.04 Cr | ₹35.99 Cr | ₹26.16 Cr | ₹16.26 Cr | ₹7.37 Cr | ₹7.35 Cr | ₹5.71 Cr | ₹19.19 Cr |
| Property, Plant & Equipment | ₹62.29 Cr | ₹60.87 Cr | ₹65.58 Cr | ₹65.38 Cr | ₹70.91 Cr | ₹74.23 Cr | ₹48.73 Cr | ₹43.11 Cr |
| Inventories | ₹0 | ₹0 | ₹84.02 Lakh | ₹0 | ₹6.08 Lakh | ₹6.19 Lakh | ₹9.41 Lakh | ₹58.42 Lakh |
| Trade Receivables | ₹8.78 Cr | ₹7.45 Cr | ₹3.25 Cr | ₹3.32 Cr | ₹3.93 Cr | ₹3.8 Cr | ₹1.86 Cr | ₹2.36 Cr |
| Cash & Equivalents | ₹30.29 Cr | ₹26.58 Cr | ₹1.82 Cr | ₹11.14 Cr | ₹2.41 Cr | ₹2.46 Cr | ₹1.08 Cr | ₹13.2 Cr |
| Equity (Net Worth) | ₹95.12 Cr | ₹96.13 Cr | ₹90.54 Cr | ₹82.27 Cr | ₹70.64 Cr | ₹48.41 Cr | ₹49.63 Cr | ₹38.9 Cr |
| Equity Share Capital | ₹61.03 Cr | ₹61.03 Cr | ₹61.03 Cr | ₹61.03 Cr | ₹61.03 Cr | ₹61.03 Cr | ₹61.03 Cr | ₹61.03 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹6 Cr | ₹20.66 Cr | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹18.66 Cr | ₹20.24 Cr |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹6 Cr | ₹20.66 Cr | ₹18.66 Cr | ₹20.24 Cr |
| Current Liabilities | ₹12.06 Cr | ₹12.59 Cr | ₹13.52 Cr | ₹16.61 Cr | ₹15.58 Cr | ₹14.95 Cr | ₹35.44 Cr | ₹45.35 Cr |
| Total Liabilities | ₹16.03 Cr | ₹14.9 Cr | ₹15.66 Cr | ₹18.6 Cr | ₹23.44 Cr | ₹37.44 Cr | ₹35.93 Cr | ₹45.69 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹10.2 Cr | ₹9.45 Cr | ₹11.83 Cr | ₹20.66 Cr | ₹17.66 Cr |
| Investing Cash Flow | -₹6.49 Cr | ₹15.29 Cr | -₹21.15 Cr | -₹5.82 Cr | -₹1.84 Cr |
| Financing Cash Flow | ₹0 | ₹0 | ₹0 | -₹6.11 Cr | -₹15.87 Cr |
| Capital Expenditure | ₹8.32 Cr | ₹3.86 Cr | ₹4.23 Cr | ₹6.23 Cr | ₹1.94 Cr |
| Free Cash Flow (computed) | ₹1.88 Cr | ₹5.59 Cr | ₹7.6 Cr | ₹14.43 Cr | ₹15.73 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹3.71 Cr | ₹24.76 Cr | -₹9.33 Cr | ₹8.73 Cr | -₹4.29 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹8.87 Cr | ₹11.83 Cr | ₹10.23 Cr | ₹8.64 Cr | ₹11.11 Cr | ₹10.22 Cr | ₹8.75 Cr | ₹9.91 Cr |
| Other Income | ₹1.61 Cr | ₹1.45 Cr | ₹1.7 Cr | ₹1.59 Cr | ₹1.51 Cr | ₹1.39 Cr | ₹1.36 Cr | ₹33.7 Lakh |
| Total Income | ₹10.48 Cr | ₹13.28 Cr | ₹11.94 Cr | ₹10.23 Cr | ₹12.62 Cr | ₹11.61 Cr | ₹10.11 Cr | ₹10.25 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹42.75 Lakh | ₹20.25 Lakh | ₹13.91 Lakh | ₹7.11 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹4.17 Cr | ₹4.02 Cr | ₹3.8 Cr | ₹3.54 Cr | ₹3.23 Cr | ₹3.18 Cr | ₹3.01 Cr | ₹2.95 Cr |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹1.76 Cr | ₹1.8 Cr | ₹1.78 Cr | ₹1.77 Cr | ₹1.73 Cr | ₹1.76 Cr | ₹1.75 Cr | ₹1.73 Cr |
| Other Expenses | ₹5.54 Cr | ₹4.57 Cr | ₹5.14 Cr | ₹3.65 Cr | ₹4 Cr | ₹3.99 Cr | ₹4.21 Cr | ₹3.45 Cr |
| Total Expenses | ₹11.47 Cr | ₹10.39 Cr | ₹10.73 Cr | ₹8.95 Cr | ₹9.39 Cr | ₹9.13 Cr | ₹9.11 Cr | ₹8.2 Cr |
| Profit Before Exceptional Items & Tax | -₹98.96 Lakh | ₹2.89 Cr | ₹1.21 Cr | ₹1.28 Cr | ₹3.24 Cr | ₹2.49 Cr | ₹1 Cr | ₹2.05 Cr |
| Exceptional Items | ₹5.41 Lakh | -₹29.89 Lakh | ₹4.97 Lakh | ₹0 | -₹4.88 Lakh | ₹62.4 Lakh | ₹1.35 Cr | ₹0 |
| Profit Before Tax | -₹93.55 Lakh | ₹2.59 Cr | ₹1.26 Cr | ₹1.28 Cr | ₹3.19 Cr | ₹3.11 Cr | ₹2.35 Cr | ₹2.05 Cr |
| Total Tax Expense | ₹2.22 Cr | ₹66.38 Lakh | ₹2.09 Cr | ₹28.72 Lakh | ₹1.96 Cr | ₹1.42 Cr | ₹1 Cr | ₹75.58 Lakh |
| Net Profit | -₹3.15 Cr | ₹1.93 Cr | -₹83.65 Lakh | ₹98.96 Lakh | ₹1.23 Cr | ₹1.69 Cr | ₹1.35 Cr | ₹1.29 Cr |
| Other Comprehensive Income | ₹6 Lakh | -₹44,000 | -₹46,000 | -₹42,000 | ₹36,000 | -₹68,000 | -₹68,000 | -₹68,000 |
| Total Comprehensive Income | -₹3.09 Cr | ₹1.92 Cr | -₹84.11 Lakh | ₹98.54 Lakh | ₹1.23 Cr | ₹1.69 Cr | ₹1.34 Cr | ₹1.28 Cr |
| EBITDA (computed) | ₹76.84 Lakh | ₹4.69 Cr | ₹2.99 Cr | ₹3.05 Cr | ₹4.96 Cr | ₹4.25 Cr | ₹2.75 Cr | ₹3.77 Cr |
| Basic EPS | ₹-0.52 | ₹0.32 | ₹0.14 | ₹0.16 | ₹0.20 | ₹0.28 | ₹0.22 | ₹0.21 |
| Diluted EPS | ₹-0.52 | ₹0.32 | ₹0.14 | ₹0.16 | ₹0.00 | ₹0.28 | ₹0.22 | ₹0.21 |
Shareholding Pattern of Zenotech Laboratories Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 68.84%, domestic institutional investors hold 0.01%, retail and other public shareholders hold 30.17% of Zenotech Laboratories Limited. The company had 10,301 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% |
| Public | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 68.84% | 68.84% | 68.84% |
| Public | 31.16% | 31.16% | 31.16% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Charges & Borrowings of Zenotech Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Oct 2005 | Technology Development Board | ₹6 Cr | Open |
| 20 Mar 2012 | Hdfc Bank Limited | ₹15 Cr | Satisfied |
| 17 Jan 2008 | Yes Bank Limited | ₹10 Cr | Satisfied |
| 24 May 2006 | Indian Overseas Bank | ₹10 Cr | Satisfied |
| 19 Jan 2006 | Andhra Bank | ₹4 Cr | Satisfied |
Total charge records: 10 View all charges
Employees and EPFO Compliance at Zenotech Laboratories Limited
Zenotech Laboratories Limited has a workforce of 181 employees as of Apr 08, 2024.
Employee Count & EPFO Data of Zenotech Laboratories Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Zenotech Laboratories Limited
GSTIN & GST Filing Data of Zenotech Laboratories Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Zenotech Laboratories Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Zenotech Laboratories Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Zenotech Laboratories Limited
MSME Payment Delays by Zenotech Laboratories Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Zenotech Laboratories Limited
Subsidiaries & Group Companies of Zenotech Laboratories Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Zenotech Laboratories Limited with ownership details.
MCA Filings & Documents of Zenotech Laboratories Limited
MCA Filings & Documents of Zenotech Laboratories Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Zenotech Laboratories Limited
Recent News on Zenotech Laboratories Limited
Frequently Asked Questions about Zenotech Laboratories Limited
Zenotech Laboratories Limited is an active public limited company in the pharma sector based in Hyd, Telangana, India. It was incorporated on 15 June 1989 (37+ years old) and is registered under CIN L27100TG1989PLC010122. Listed on BSE: 532039. The company has 181 employees.
Zenotech Laboratories Limited reported revenue of ₹44.6 Cr for FY 2025 (up 7.00% YoY).
The current directors of Zenotech Laboratories Limited are:
- Rakeshchandra Jagdishprasad Sinha
- Jignesh Anantray Goradia
- Premal Hemant Gandhi
- Abdul Gafoor Mohammad
- Chintan Jitendra Shah
- Kachappilly Varghese
- Jagruti Prashant Sheth
- Azadar Husain Asghar Mehdi Khan
- Kachappilly Varghese Poly
- Sachin Laxmanappa Gavandare
The primary industry of Zenotech Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Zenotech Laboratories Limited is listed on BSE with code 532039.
Zenotech Laboratories Limited can be reached at the registered office: Survey No.250 – 252 Turkapally Village Genome Valley Road, Shamirpet Mandal Medchal – Malkajgiri District, Hyd, Telangana, India – 500101, or through the website zenotechlab.com.